HomeTVRD • NASDAQ
add
Tvardi Therapeutics Inc
Previous close
$4.66
Day range
$4.49 - $4.91
Year range
$4.48 - $43.65
Market cap
43.61M USD
Avg Volume
503.28K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.87M | 23.51% |
Net income | 4.17M | 159.74% |
Net profit margin | — | — |
Earnings per share | 0.51 | 104.10% |
EBITDA | -8.85M | -23.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 40.99M | -27.60% |
Total assets | 43.75M | -39.65% |
Total liabilities | 10.82M | -82.23% |
Total equity | 32.93M | — |
Shares outstanding | 9.38M | — |
Price to book | 1.33 | — |
Return on assets | -61.97% | — |
Return on capital | -81.97% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 4.17M | 159.74% |
Cash from operations | -5.87M | -119.04% |
Cash from investing | -9.55M | -162.46% |
Cash from financing | 24.63M | — |
Net change in cash | 9.21M | 443.75% |
Free cash flow | -2.20M | 66.86% |
About
Founded
2004
Headquarters
Website
Employees
11
